MedTrace Logo

Bone Anchored Carriere Motion Appliance

NCT05499221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-07-09

No results posted yet for this study

Summary

Carriere Motion appliance (CMA) was designed to change a Class II molar relationship into a Class I relationship by distalizing the whole posterior maxillary segment by means of class II elastics and mandibular anchorage. To eliminate the adverse effects of CMA with class II elastics, we can use the CMA to distalize the maxillary posterior segment with intra-arch anchorage using infrazygomatic miniscrews. The aim of this study is to evaluate skeletaly anchored CMA for distalization of the maxillary buccal segment vs. conventionally anchored CMA by comparing skeletal and dental measurements obtained from lateral cephalometric radiographs obtained prior to treatment (T0) and immediately after correction of class II and remval of the appliance (T1).

Conditions

  • Malocclusion, Angle Class II

Interventions

DEVICE

Carriere motion appliance

The CMA will be bonded on the permanent maxillary canine and first molar, and the correct size is chosen according to the manufacturer's instructions.

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Eglal A. Ghozy, BDS, MDS · Mansoura University

  • Ahmed A. El-bialy, PhD · Mansoura University

  • Marwa S. Shamaa, PhD · Mansoura University

  • Nehal F. Albelasy, PhD · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-26
Primary Completion
2023-06-26
Completion
2023-08-26
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05499221 on ClinicalTrials.gov